Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association between ethnicity, socioeconomic position and outcomes following initiation of methotrexate in juvenile idiopathic arthritis.

EULAR rheumatology open·2026
Same author

Executive Summary: The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus.

Rheumatology (Oxford, England)·2026
Same author

The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus.

Rheumatology (Oxford, England)·2026
Same author

The association between ethnicity, socioeconomic position and outcomes following initiation of TNF inhibitors in juvenile idiopathic arthritis: results from the UK JIA Biologics Register.

Rheumatology (Oxford, England)·2026
Same author

Effective Performance of the 2022 American College of Rheumatology/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Pediatric Patients: An ARChiVe Study.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Validating treat-to-target endpoints in childhood lupus: data-driven sensitivity analyses from the UK JSLE cohort study.

Rheumatology (Oxford, England)·2026

Related Experiment Videos

Adding to complexity: comorbidity in paediatric rheumatic disease.

Eve M D Smith1, Helen E Foster, Michael W Beresford

  • 1Paediatric Rheumatology, Great North Children's Hospital, Queen Victoria Road, Newcastle Upon Tyne NE1 4LP, UK. evemdsmith@yahoo.co.uk

Rheumatology (Oxford, England)
|October 2, 2012
PubMed
Summary
This summary is machine-generated.

Novel biologic therapies improve outcomes for children with rheumatic diseases. Addressing comorbidities like cardiovascular, renal, and growth issues is crucial for enhancing quality of life and treatment effectiveness.

Related Experiment Videos

Area of Science:

  • Pediatric Rheumatology
  • Internal Medicine
  • Clinical Therapeutics

Background:

  • Biologic agents represent novel therapies for pediatric rheumatic diseases.
  • Comorbidities associated with rheumatic diseases and their treatments present significant challenges.
  • Effective management of comorbidities is vital for improving patient outcomes.

Purpose of the Study:

  • To review key comorbidities frequently encountered in pediatric rheumatology.
  • To highlight the importance of prompt recognition and management of these comorbidities.
  • To discuss the impact of rheumatic diseases and treatments on various aspects of child health.

Main Methods:

  • Literature review of comorbidities in pediatric rheumatology.
  • Discussion of cardiovascular, renal, genito-urinary, and visual comorbidities.
  • Analysis of bone health, drug-related issues, growth, and puberty impacts.

Main Results:

  • Biologic therapies offer improved long-term prognosis for children with rheumatic diseases.
  • Comorbidities significantly impact quality of life and treatment effectiveness.
  • Specific areas of comorbidity include cardiovascular, renal, genito-urinary, visual, bone health, and growth/puberty.

Conclusions:

  • Prompt recognition and management of comorbidities are essential in pediatric rheumatology.
  • Addressing comorbidities optimizes treatment effectiveness and overall prognosis.
  • Comprehensive care considering comorbidities improves long-term outcomes for children with rheumatic diseases.